ErbB3-binding protein EBP1 decreases ErbB2 levels via a transcriptional mechanism

Ghosh,Arundhati; Awasthi,Smita; Hamburger,Anne  W.

doi:10.3892/or.2012.2186

ErbB3-binding protein EBP1 decreases ErbB2 levels via a transcriptional mechanism

Authors:
- Arundhati Ghosh
- Smita Awasthi
- Anne W. Hamburger
View Affiliations

Affiliations: Greenebaum Cancer Center, University of Maryland, Baltimore, MD 21201, USA
Published online on: December 14, 2012 https://doi.org/10.3892/or.2012.2186
Pages: 1161-1166

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Ectopic expression of EBP1, an ErbB3-interacting protein, reduces the expression of the ErbB2 protein and mRNA. However, the mechanism of EBP1-induced decrease in ErbB2 mRNA levels has not yet been determined. Since EBP1 affects both transcriptional and post-transcriptional processes, we evaluated the ability of EBP1 to regulate ErbB2 transcription and RNA stability. We discovered that while wild-type EBP1 decreased the activity of a proximal ErbB2 promoter, EBP1 mutants unable to interact with the Sin3A transcriptional repressor inhibited activity to a lesser extent. EBP1 also decreased the activity of distal ErbB2 promoters. Chromatin immunoprecipitation analysis indicated that EBP1 bound both distal and proximal endogenous ErbB2 promoters in serum-starved conditions. The ErbB3 ligand heregulin (HRG) at growth-promoting concentrations reduced EBP1 binding to the ErbB2 promoter. Although endogenous EBP1 bound ErbB2 mRNA, EBP1 overexpression or ablation of EBP1 protein by shRNA failed to alter ErbB2 mRNA stability. These results suggest that the major effect of EBP1 on ErbB2 mRNA levels is at the transcriptional level.

View Figures

View References

1	Yoo JY, Wang XW, Rishi AK, Lessor T, Xia XM, Gustafson TA and Hamburger AW: Interaction of the PA2G4 (EBP1) protein with ErbB-3 and regulation of this binding by heregulin. Br J Cancer. 82:683–690. 2000.PubMed/NCBI
2	Lessor TJ, Yoo JY, Xia X, Woodford N and Hamburger AW: Ectopic expression of the ErbB-3 binding protein Ebp1 inhibits growth and induces differentiation of human breast cancer cell lines. J Cell Physiol. 183:321–329. 2000. View Article : Google Scholar : PubMed/NCBI
3	Yamada H, Mori H, Momoi H, Nakagawa Y, Ueguchi C and Mizuno T: A fission yeast gene encoding a protein that preferentially associates with curved DNA. Yeast. 10:883–894. 1994. View Article : Google Scholar : PubMed/NCBI
4	Zhang Y and Hamburger AW: Heregulin regulates the ability of the ErbB3-binding protein Ebp1 to bind E2F promoter elements and repress E2F-mediated transcription. J Biol Chem. 279:26126–26133. 2004. View Article : Google Scholar : PubMed/NCBI
5	Monie TP, Perrin AJ, Birtley JR, Sweeney TR, Karakasiliotis I, Chaudhry Y, Roberts LO, Matthews S, Goodfellow IG and Curry S: Structural insights into the transcriptional and translational roles of Ebp1. EMBO J. 26:3936–3944. 2007. View Article : Google Scholar : PubMed/NCBI
6	Ahn JY, Liu X, Liu Z, Pereira L, Cheng D, Peng J, Wade PA, Hamburger AW and Ye K: Nuclear Akt associates with PKC-phosphorylated Ebp1, preventing DNA fragmentation by inhibition of caspase-activated DNase. EMBO J. 25:2083–2095. 2006. View Article : Google Scholar : PubMed/NCBI
7	Radomski N and Jost E: Molecular cloning of a murine cDNA encoding a novel protein, p38-2G4, which varies with the cell cycle. Exp Cell Res. 220:434–445. 1995. View Article : Google Scholar : PubMed/NCBI
8	Zhang YX, Woodford N, Xia XM and Hamburger AW: Repression of E2F1-mediated transcription by the ErbB3 binding protein Ebp1 involves histone deacetylases. Nucleic Acid Res. 31:2168–2177. 2003. View Article : Google Scholar : PubMed/NCBI
9	Zhang YX, Fondell JD, Wang QB, Xia XM, Cheng AW, Lu ML and Hamburger AW: Repression of androgen receptor mediated transcription by the ErbB-3 binding protein, Ebp1. Oncogene. 21:5609–5618. 2002. View Article : Google Scholar : PubMed/NCBI
10	Zhang Y, Wang XW, Jelovac D, Nakanishi T, Yu MH, Akinmade D, Goloubeva O, Ross DD, Brodie A and Hamburger AW: The ErbB3-binding protein Ebp1 suppresses androgen receptor-mediated gene transcription and tumorigenesis of prostate cancer cells. Proc Natl Acad Sci USA. 102:9890–9895. 2005. View Article : Google Scholar : PubMed/NCBI
11	Zhang Y, Akinmade D and Hamburger AW: The ErbB3 binding protein Ebp1 interacts with Sin3A to repress E2F1 and AR-mediated transcription. Nucleic Acid Res. 33:6024–6033. 2005. View Article : Google Scholar : PubMed/NCBI
12	Squatrito M, Mancino M, Donzelli M, Areces LB and Draetta GF: EBP1 is a nucleolar growth-regulating protein that is part of pre-ribosomal ribonucleoprotein complexes. Oncogene. 23:4454–4465. 2004. View Article : Google Scholar : PubMed/NCBI
13	Squatrito M, Mancino M, Sala L and Draetta GF: Ebp1 is a dsRNA-binding protein associated with ribosomes that modulates eIF2alpha phosphorylation. Biochem Biophys Res Commun. 344:859–868. 2006. View Article : Google Scholar : PubMed/NCBI
14	Zhou H, Mazan-Mamczarz K, Martindale JL, Barker A, Liu Z, Gorospe M, Leedman PJ, Gartenhaus RB, Hamburger AW and Zhang Y: Post-transcriptional regulation of androgen receptor mRNA by an ErbB3 binding protein 1 in prostate cancer. Nucleic Acids Res. 38:3619–3631. 2010. View Article : Google Scholar : PubMed/NCBI
15	Bose SK, Sengupta TK, Bandyopadhyay S and Spicer EK: Identification of Ebp1 as a component of cytoplasmic bcl-2 mRNP (messenger ribonucleoprotein particle) complexes. Biochem J. 396:99–107. 2006. View Article : Google Scholar : PubMed/NCBI
16	Corso C, Pisapia L, Citro A, Cicatiello V, Barba P, Cigliano L, Abrescia P, Maffei A, Manco G and Del Pozzo G: EBP1 and DRBP76/NF90 binding proteins are included in the major histocompatibility complex class II RNA operon. Nucleic Acids Res. 39:7263–7275. 2011. View Article : Google Scholar : PubMed/NCBI
17	Akinmade D, Lee M, Zhang Y and Hamburger AW: Ebp1-mediated inhibition of cell growth requires serine 363 phosphorylation. Int J Oncol. 31:851–858. 2007.PubMed/NCBI
18	Akinmade D, Talukder AH, Zhang Y, Luo WM, Kumar R and Hamburger AW: Phosphorylation of the ErbB3 binding protein Ebp1 by p21-activated kinase 1 in breast cancer cells. Br J Cancer. 98:1132–1140. 2008. View Article : Google Scholar : PubMed/NCBI
19	Zhang Y and Hamburger AW: Specificity and heregulin regulation of Ebp1 (ErbB3 binding protein 1) mediated repression of androgen receptor signalling. Br J Cancer. 92:140–146. 2005. View Article : Google Scholar : PubMed/NCBI
20	Zhang Y, Akinmade D and Hamburger AW: Inhibition of heregulin mediated MCF-7 breast cancer cell growth by the ErbB3 binding protein EBP1. Cancer Lett. 265:298–306. 2008. View Article : Google Scholar : PubMed/NCBI
21	Lu Y, Zhou H, Chen W, Zhang Y and Hamburger AW: The ErbB3 binding protein EBP1 regulates ErbB2 protein levels and tamoxifen sensitivity in breast cancer cells. Breast Cancer Res Treat. 126:27–36. 2011. View Article : Google Scholar : PubMed/NCBI
22	Scott GK, Marx C, Berger CE, Saunders LR, Verdin E, Schafer S, Jung M and Benz CC: Destabilization of ERBB2 transcripts by targeting 3′ untranslated region messenger RNA associated HuR and histone deacetylase-6. Mol Cancer Res. 6:1250–1258. 2008.PubMed/NCBI
23	Delacroix L, Begon D, Chatel G, Jackers P and Winkler R: Distal ERBB2 promoter fragment displays specific transcriptional and nuclear binding activities in ERBB2 overexpressing breast cancer cells. DNA Cell Biol. 24:582–594. 2005. View Article : Google Scholar
24	Hua G, Zhu B, Rosa F, Deblon N, Adelaide J, Kahn-Perles B, Birnbaum D and Imbert J: A negative feedback regulatory loop associates the tyrosine kinase receptor ERBB2 and the transcription factor GATA4 in breast cancer cells. Mol Cancer Res. 7:402–414. 2009. View Article : Google Scholar : PubMed/NCBI
25	Shang Y, Myers M and Brown M: Formation of the androgen receptor transcription complex. Mol Cell. 9:601–610. 2002. View Article : Google Scholar : PubMed/NCBI
26	Hynes NE and Lane HA: ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer. 5:341–354. 2005. View Article : Google Scholar : PubMed/NCBI
27	Benz CC, O’Hagan RC, Richter B, Scott GK, Chang CH, Xiong X, Chew K, Ljung BM, Edgerton S, Thor A and Hassell JA: HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer. Oncogene. 15:1513–1525. 1997. View Article : Google Scholar : PubMed/NCBI
28	Hurst HC: Update on HER-2 as a target for cancer therapy: the ERBB2 promoter and its exploitation for cancer treatment. Breast Cancer Res. 3:395–398. 2001. View Article : Google Scholar : PubMed/NCBI
29	Qin HR, Iliopoulos D, Nakamura T, Costinean S, Volinia S, Druck T, Sun J, Okumura H and Huebner K: Wwox suppresses prostate cancer cell growth through modulation of ErbB2-mediated androgen receptor signaling. Mol Cancer Res. 5:957–965. 2007. View Article : Google Scholar : PubMed/NCBI
30	Lewis GD, Lofgren JA, McMurtrey AE, Nuijens A, Fendly BM, Bauer KD and Sliwkowski MX: Growth regulation of human breast and ovarian tumor cells by heregulin: Evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsiveness. Cancer Res. 56:1457–1465. 1996.
31	Diermeier-Daucher S, Breindl S, Buchholz S, Ortmann O and Brockhoff G: Modular anti-EGFR and anti-Her2 targeting of SK-BR-3 and BT474 breast cancer cell lines in the presence of ErbB receptor-specific growth factors. Cytometry A. 79:684–693. 2011.PubMed/NCBI